Regulation of Cytokines/Chemokines Release and Anti-Tumor Effect of Expanded Natural Killer (NK) Cells By a Novel Fusion of N-820 (2B8T2M), an IL-15 Superagonist with 4 Single-Chain Anti-CD20 Antibody Domains, Against Rituximab Resistant Burkitt Lymphoma (BL)
Document Type
Abstract
Publication Date
11-2018
Journal Title
Blood
Department
Pediatrics
Second Department
Health Behavior and Community Health
Recommended Citation
Chu, Y., Su, N., Jeng, E. K., Alter, S., Rhode, P. R., Lee, J. H., Nayyar, G., Barth, M., Lee, D. A., Wong, H. C., & Cairo, M. (2018). Regulation of Cytokines/Chemokines Release and Anti-Tumor Effect of Expanded Natural Killer (NK) Cells By a Novel Fusion of N-820 (2B8T2M), an IL-15 Superagonist with 4 Single-Chain Anti-CD20 Antibody Domains, Against Rituximab Resistant Burkitt Lymphoma (BL). Blood, 132 (Suppl. 1), 3697. Retrieved from https://touroscholar.touro.edu/nymc_fac_abstracts/226
COinS